Inhibition of Autophagy Facilitates XY03-EA-Mediated Neuroprotection against the Cerebral Ischemia/Reperfusion Injury in Rats.

Oxid Med Cell Longev · 2022 · PMC8986424 · PMID 35401933

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

a strong trendp = 0.054so close (0.05 < p ≤ 0.1)

It showed that there was a strong trend for SOD activity to decrease ( p = 0.054) and the content of GSH decreased significantly ( p < 0.01).

also in 5,725 other papers

a decreasing trendno p-value reported

Compared with the MCAO/R group, the Zea Longa scores of the treatment groups significantly decreased ( P < 0.05, P < 0.01), except that the XY03-EA 50 mg/kg group showed a decreasing trend ( Figure 3(b) ). 3.2.

also in 47,180 other papers

a positive trendno p-value reported

In the nonhuman primate MCAO/R model, the treatment of XY03-EA for 3 weeks could significantly inhibit the NDS progression rate and indicate a positive trend to reduce the infarct volume in a dose-dependent way.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.